Systemic inflammatory response to smoking in chronic obstructive pulmonary disease: Evidence of a gender effect

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Faner, Rosa ^a,b,c   Gonzalez, Nuria ^a   Cruz, Tamara ^a,b   Kalko, Susana Graciela ^b   Agustí, Alvar ^a,b,c,d,e  

^a Fundacio Clinic Per a la Recerca Biomedica   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

^e Fundació Investigació Sanitària Illes Balears FISIB   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRINCIPAL COMPONENT ANALYSIS; PROSPECTIVE STUDY; SEX DIFFERENCE; SMOKING; SPIROMETRY; TRANSCRIPTOMICS; CASE CONTROL STUDY; CLUSTER ANALYSIS; DNA MICROARRAY; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IMMUNOLOGY; LUNG; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TOBACCO;

AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; LEUKOCYTES; LUNG; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; PRINCIPAL COMPONENT ANALYSIS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEX FACTORS; SMOKING; SPIROMETRY; TOBACCO;

EID: 84901313491     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097491     Document Type: Article

References (48)

1. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, et al. (2013) Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease, GOLD Executive Summary. Am J Respir Crit Care Med 187: 347-365. rccm.201204-0596PP [pii];10.1164/rccm.201204-0596PP [doi].
2. Fletcher C, Peto R (1977) The natural history of chronic airflow obstruction. Br Med J 1: 1645-1648. (Pubitemid 8124466)
3. Lomas DA, Silverman EK (2001) The genetics of chronic obstructive pulmonary disease. Respir Res 2: 20-26. (Pubitemid 34187903)
4. Silverman EK, Speizer FE, Weiss ST, Chapman HA Jr, Schuette A, et al. (2000) Familial aggregation of severe, early-onset COPD: candidate gene approaches. Chest 117: 273S-274S. (Pubitemid 30326987)
5. DeMeo DL, Carey VJ, Chapman HA, Reilly JJ, Ginns LC, et al. (2004) Familial aggregation of FEF25-75 and FEF25-75/FVC in families with severe, early onset COPD. Thorax 59: 396-400. (Pubitemid 38624745)
6. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, et al. (2004) The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease. N Engl J Med 350: 2645-2653. (Pubitemid 38787999)
7. Agusti A, Edwards LD, Rennard SI, MacNee W, Tal-Singer R, et al. (2012) Persistent Systemic Inflammation is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype. PLoS ONE 7: e37483.
8. Aryal S, Diaz-Guzman E, Mannino DM (2013) COPD and gender differences: an update. Transl Res 162: 208-218. S1931-5244(13)00138-2 [pii];10.1016/j.trsl. 2013.04.003 [doi].
9. de Torres JP, Casanova C, Hernandez C, Abreu J, guirre-Jaime A, et al. (2005) Gender and COPD in patients attending a pulmonary clinic. Chest 128: 2012-2016.
10. Dransfield MT, Washko GR, Foreman MG, San Jose ER, Reilly J, et al. (2007) Gender differences in the severity of CT emphysema in COPD. Chest.
11. McDunn JE, Husain KD, Polpitiya AD, Burykin A, Ruan J, et al. (2008) Plasticity of the systemic inflammatory response to acute infection during critical illness: development of the riboleukogram. PLoS ONE 3: e1564. 10.1371/journal.pone.0001564 [doi].
12. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, et al. (2007) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176: 532-555. (Pubitemid 47403272)
13. van der Vaart H, Postma DS, Timens W, Hylkema MN, Willemse BW, et al. (2005) Acute effects of cigarette smoking on inflammation in healthy intermittent smokers. Respir Res 6: 22.
14. van der Vaart H, Postma DS, Timens W, ten Hacken NH (2004) Acute effects of cigarette smoke on inflammation and oxidative stress: a review. Thorax 59: 713-721. (Pubitemid 39061538)
15. American Thoracic Society Official Statement (1995) Standardization of Spirometry. 1994 Update. Am J Respir Crit Care Med 152: 1107-1136.
16. Roca J, Sanchis J, Agustí-Vidal A, Segarra J, Navajas D, et al. (1986) Spirometric reference values for a mediterranean population. Bull Eur Physiopathol Respir 22: 217-224. (Pubitemid 16116729)
17. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. 10.1006/meth.2001.1262 [doi];S1046-2023(01)91262-9 [pii].
18. Breitling R, Armengaud P, Amtmann A, Herzyk P (2004) Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett 573: 83-92. 10.1016/j.febslet.2004. 07.055 [doi];S0014579304009354 [pii].
19. Huang dW, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57. nprot.2008.211 [pii];10.1038/nprot.2008.211 [doi].
20. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, et al. (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4: 3.
21. Jimenez-Marin A, Collado-Romero M, Ramirez-Boo M, Arce C, Garrido JJ (2009) Biological pathway analysis by ArrayUnlock and Ingenuity Pathway Analysis. BMC Proc 3 Suppl 4: S6. 1753-6561-3-S4-S6 [pii];10.1186/1753-6561-3- S4-S6 [doi].
22. Smoot M, Ono K, Ideker T, Maere S (2011) PiNGO: a Cytoscape plugin to find candidate genes in biological networks. Bioinformatics 27: 1030-1031. btr045 [pii];10.1093/bioinformatics/btr045 [doi].
23. Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T (2011) Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 27: 431-432. btq675 [pii];10.1093/bioinformatics/btq675 [doi].
24. Menon R, Di DM, Cordiglieri C, Musio S, La ML, et al. (2012) Gender-based blood transcriptomes and interactomes in multiple sclerosis: involvement of SP1 dependent gene transcription. J Autoimmun 38: J144-J155. S0896-8411(11)00117-X [pii];10.1016/j.jaut.2011.11.004 [doi].
25. Anton IM, de la Fuente MA, Sims TN, Freeman S, Ramesh N, et al. (2002) WIP deficiency reveals a differential role for WIP and the actin cytoskeleton in T and B cell activation. Immunity 16: 193-204. S1074761302002686 [pii].
26. Vogler M (2012) BCL2A1: the underdog in the BCL2 family. Cell Death Differ 19: 67-74. cdd2011158 [pii];10.1038/cdd.2011.158 [doi].
27. Lang F, Voelkl J (2013) Therapeutic potential of serum and glucocorticoid inducible kinase inhibition. Expert Opin Investig Drugs 22: 701-714. 10.1517/13543784.2013.778971 [doi].
28. Bailey SL, Chang SC, Griffiths B, Graham AN, Saffery R, et al. (2008) ZNF397, a new class of interphase to early prophase-specific, SCAN-zinc-finger, mammalian centromere protein. Chromosoma 117: 367-380. 10.1007/s00412-008-0155-7 [doi].
29. Eisenreich A, Zakrzewicz A, Huber K, Thierbach H, Pepke W, et al. (2013) Regulation of pro-angiogenic tissue factor expression in hypoxia-induced human lung cancer cells. Oncol Rep 30: 462-470. 10.3892/or.2013.2413 [doi].
30. Luo Y, Roeder RG (1995) Cloning, functional characterization, and mechanism of action of the B-cell-specific transcriptional coactivator OCA-B. Mol Cell Biol 15: 4115-4124.
31. Gotting C, Kuhn J, Zahn R, Brinkmann T, Kleesiek K (2000) Molecular cloning and expression of human UDP-d-Xylose:proteoglycan core protein beta-d-xylosyltransferase and its first isoform XT-II. J Mol Biol 304: 517-528. 10.1006/jmbi.2000.4261 [doi];S0022-2836(00)94261-X [pii].
32. Schonthaler HB, Guinea-Viniegra J, Wagner EF (2011) Targeting inflammation by modulating the Jun/AP-1 pathway. Ann Rheum Dis 70 Suppl 1: i109-i112.70/Suppl-1/i109 [pii];10.1136/ard.2010.140533 [doi].
33. Bahr TM, Hughes GJ, Armstrong M, Reisdorph R, Coldren CD, et al. (2013) Peripheral Blood Mononuclear Cell Gene Expression in Chronic Obstructive Pulmonary Disease. Am J Respir Cell Mol Biol.
34. Bhattacharya S, Tyagi S, Srisuma S, DeMeo DL, Shapiro SD, et al. (2011) Peripheral blood gene expression profiles in COPD subjects. J Clin Bioinforma 1: 12. 2043-9113-1-12 [pii];10.1186/2043-9113-1-12 [doi].
35. Kohansal R, Martinez-Camblor P, Agusti A, Buist AS, Mannino DM, et al. (2009) The Natural History of Chronic Airflow Obstruction Revisited: An Analysis of the Framingham Offspring Cohort. Am J Respir Crit Care Med 180: 3-10. 200901-0047OC [pii];10.1164/rccm.200901-0047OC [doi].
36. de Torres JP, Casanova C, Pinto-Plata V, Varo N, Restituto P, et al. (2011) Gender Differences in Plasma Biomarker Levels in a Cohort of COPD Patients: A Pilot Study. PLoS ONE 6: e16021. 10.1371/journal.pone.0016021 [doi].
37. Roeters van Lennep JE, Westerveld HT, Erkelens DW, van der Wall EE (2002) Risk factors for coronary heart disease: implications of gender. Cardiovasc Res 53: 538-549.
38. Erbel R, Mohlenkamp S, Lehmann N, Schmermund A, Moebus S, et al. (2008) Sex related cardiovascular risk stratification based on quantification of atherosclerosis and inflammation. Atherosclerosis 197: 662-672. S0021-9150(07)00132-3 [pii];10.1016/j.atherosclerosis.2007.02.031 [doi].
39. Zhu J, Shearer GM, Norman JE, Pinto LA, Marincola FM, et al. (2000) Host response to cytomegalovirus infection as a determinant of susceptibility to coronary artery disease: sex-based differences in inflammation and type of immune response. Circulation 102: 2491-2496.
40. Gawron A, Hou L, Ning H, Berry JD, Lloyd-Jones DM (2012) Lifetime risk for cancer death by sex and smoking status: the lifetime risk pooling project. Cancer Causes Control 23: 1729-1737. 10.1007/s10552-012-9959-0 [doi].
41. Ryu JS, Jeon SH, Kim JS, Lee JH, Kim SH, et al. (2011) Gender differences in susceptibility to smoking among patients with lung cancer. Korean J Intern Med 26: 427-431. 10.3904/kjim.2011.26.4.427 [doi].
42. Park SK, Cho LY, Yang JJ, Park B, Chang SH, et al. (2010) Lung cancer risk and cigarette smoking, lung tuberculosis according to histologic type and gender in a population based case-control study. Lung Cancer 68: 20-26. S0169-5002(09)00318-3 [pii];10.1016/j.lungcan.2009.05.017 [doi].
43. Menon R, Di DM, Cordiglieri C, Musio S, La ML, et al. (2012) Gender-based blood transcriptomes and interactomes in multiple sclerosis: involvement of SP1 dependent gene transcription. J Autoimmun 38: J144-J155. S0896-8411(11)00117-X [pii];10.1016/j.jaut.2011.11.004 [doi].
44. Pennell LM, Galligan CL, Fish EN (2012) Sex affects immunity. J Autoimmun 38: J282-J291. S0896-8411(11)00126-0 [pii];10.1016/j.jaut.2011.11.013 [doi].
45. Zeng H, Kong X, Peng H, Chen Y, Cai S, et al. (2012) Apoptosis and Bcl-2 family proteins, taken to chronic obstructive pulmonary disease. Eur Rev Med Pharmacol Sci 16: 711-727.
46. Ryter SW, Lee SJ, Choi AM (2010) Autophagy in cigarette smoke-induced chronic obstructive pulmonary disease. Expert Rev Respir Med 4: 573-584. 10.1586/ers.10.61 [doi].
47. Barrero CA, Perez-Leal O, Aksoy M, Moncada C, Ji R, et al. (2013) Histone 3.3 participates in a self-sustaining cascade of apoptosis that contributes to the progression of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 188: 673-683. 10.1164/rccm.201302-0342OC [doi].
48. Faner R, Tal-Singer R, Riley JH, Celli B, Vestbo J+, et al. (2013) Lessons from ECLIPSE: a review of COPD biomarkers. Thorax. In press.